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Human skin fibroblasts were exposed to 3 anti-inflam-
matory steroids in order to study tbeir effects on the 
glycosaminoglycan metabolism. The potent glucocorti-
coids, fluocinolone acetonide and budesonide, even at 
low concentrations strongly reduced the accumulation 
of hyaluronic acid and sulfated glycosaminoglycans in 
the medium, at the cell surface, and in the cells. Hydro-
cortisone had considerably less effect. The 3 compart-
ments were not influenced to the same extent and the 
least inhibition was noted in the cell surface pool. Der-
matan sulfate was decreased to the same relative extent 
in all 3 compartments, while hyaluronic acid and hep-
aran sulfate were specifically retained at the cell surface, 
explaining why this compartment was less affected than 
the others. 
Dermatan sulfate was studied in more detail regarding 
effects on its copolymeric structure. Glucocorticoid 
treatment changed the uronosyl composition of the poly-
saccharides so that a relative decrease of glucuronic acid 
residues and a relative increase ofiduronic acid residues 
were noted. This change was most evident in dermatan 
sulfate of the medium and of the cell surface. 
Thus, glucocorticoid treatment not only reduces the 
quantity of various glycosaminoglycans but also 
changes the distribution, the relative proportion, and 
the structure of connective tissue ·proteoglycans. These 
effects probably contribute to the development of skin 
atrophy, which often is observed after long-term treat-
ment witb potent glucocorticoids. 
The long-term use of potent glucocorticoids often induces 
profound changes of connective tissue. In skin, such therapy 
may provoke thinning or, in more severe cases, atrophy of the 
skin, induction of striae, or impaired wound healing [1]. The 
mechanisms behind the development of these events are only 
partly unde{.stood. The effects of gl.ucocorticoids on cultured 
dermal fibroblasts as well as on epidermal cells have been 
thoroughly investigated. Thus it .is already known that gluco-
corticoids in therapeutic doses can inhibit cell proliferation and 
mitosis [2J, decrease collagen and glycosaminoglycan synthesis 
[3-7], and in higher doses they also have an inhibitory effect on 
the general protein synthesis [8]. These effects on cellular 
processes have been regarded as an explanation of the skin 
atrophy observed after prolonged treatment with glucocorti-
coids in vivo. 
Model experiments with topical application of potent gluco-
corticoids to rat skin have shown that loss of glycosaminogly-
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cans and water are among the first changes to appear in skin 
(Sarnstrand, unpublished). It was therefore considered of inter-
est to study the effect of glucocorticoids on the metabolism of 
glycosaminoglycans in cultured dermal fibroblast. The aim was 
to see whether glucocorticoid-induced inhibition of glycosami-
noglycan metabolism is specific or only related to the general 
catabolic effects. Three glucocorticoids were tested: hydrocor-
tisone as an endogenous glucocorticoid of low potency, and 
fluocinolone acetonide and budesonide [9,10] of high anti-in-
flammatory potency. All these are used in topical dermatologic 
therapy. The results show that at least the 2 potent glucocor-
ticoids have specific actions on the glycosaminoglycan synthesis 
and distribution. 
MATERIALS AND METHODS 
Materials 
Papain (E.C. 3.4.4.10, twice crystall ized) , trypsin (E.C. 3.4.21.4) and 
L-cystine HCI were purchased from Sigma Chemical Co., St. Louis, 
Missouri. Eagle's minimal essential medium, calf -serum, and aU other 
items needed for cell cul tures were obtained from Flow Laboratories, 
Irvine, Ayrshire, U.K Carrier-free Na?"SO" (124 mCi/mmol) , D-
[l-"H]-glucosamine HCI (2.8 Ci/mmol) and L-[ 4.5-"H]-leucine (150 Cij 
010101) were purchased from T he Radiochemical Centre, Amersham, 
Buchs, U.K. Chondroitinase-AC and -ABC (E.C. 4,2.2.5 and E.C. 
4.2.2.4) were bought from Miles Laboratories, E lkhart, Indiana. Seph-
ad ex G-50 was obtained from Phru'macia Fine Chemicals, Uppsala, 
Sweden, and DEAE-cellulose DE-52 from Whatman Inc. (WR Balston, 
Ltd., Maidstone, Kent, UK).lnstagel was bought fTom Packard Instru-
ment AB, Bandhagen, Sweden. Hyaluronate was bought from Sigma, 
derma tan sulfate and hepru'an sulfate were prepru'ed from pig skin [ll] 
and from heparin side fraction from bovine lung [12], respectively, 
Hydrocortisone was obtained from Apoteksbolaget, Sweden, Huocino-
lone acetonide from Lark, Italy, and budesonide from AB Dl'aco, 
Sweden [9]. The steroids were prepru·ed as stock solutions in concen-
tration li·om 5 x 10- 2 M to 5 x lO- ij M in absolu te ethanol. Other 
chemicals were of analytical grade. 
Culture Methods 
Fetal human skin fibroblasts were maintained in 75-cm~ culture glass 
flasks as monolayer, as described by Malmstrom et al [13]. For the 
different experiments cells were cultw·ed in 2.3-cm2 (FB-16-24-TC, 
Linbro) or 25-cm2 plastic flasks (Falcon) . At conlluency, sulfate-pool' 
medium was added [12] and after 24 Ill' exchanged for fresh medium 
containing steroids at concentrations of 10- "-10- 11 M, (Final ethanol 
concentration of 0.02%.) After 24 hI' Na2:)C,SO" (10 !lCi/ml) and ["H]-
glucosamine (2.5 !lCi/ ml) were added. 
After 48 hr of isotope incorporation the medium was collected and 
the cell layer was washed twice with 2 ml cold, phosphate-buffered 
saline (PBS), 137 mM NaCI/3 mM KCII8 mM Na2HPO,,/ 1 mM KH2PO,,, 
pH 7.4. The washings were combined with the medium. This fraction 
was designated the medium. T he ceUs were brought in to suspension by 
treatment with 3 ml prewarmed 0.4 % trypsin in PBS for 15 min at 22°C 
with occasional gentle shaking and then recovered by centrifugation at 
600 x g (2000 rpm) for 5 min and washed 4 times with PBS. The 
wash ings were combined with the ceU-free trypsin digest supernatant. 
This fraction was designated the cell sw'face pool. Both the trypsin 
digest and the medium were centrifuged at 10,000 x g for 10 min to 
remove all cellular debris. 
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The ceUs were suspended in 1 011 water and were treated with 5 
freeze-thaw cycles or with son ication. This fraction was designated the 
ceU pool. 
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I solation of Glycosam.inoglycan 
Carrier solu t ion, to give a final concentration of 0.1 mg hyaluronic 
acid, 0.05 mg derma tan sulfate, and 0.05 mg hepru·an sulfate, was added 
to all 3 fractions referred to before papain digestion. Papain (3 X 6 U) 
a nd digest buffer were added to give a final concent ration of 1.0 M 
NaCI , 0.05 M EDTA, 0.01 M cysteine-HCI, 0.05 M sodium phosphate, 
pH 7.0. The samples were then kept at 65°C for 24 hr. 
The digest was diluted 10 times and applied to ion-exchange chro-
matography columns of DE-52 DEAE cellulose (1 x 2.5 cm bed volume) 
equilibrated with 0.2 M LiCI conta ining 6 M m ea and 0.05 M sodium 
acetate, pH 4.0. The columns were elu ted stepwise with 2 X 10 ml of 
the equilibrating buffer to get rid of nonincorporated material, followed 
by 2 X 5 ml 0.35 M 2 X 5 ml 0.4 M ; 2 x 5 ml 0.8 M LiCI, all in 6 M urea 
and 0.05 M sodium acetate, pH 4.0. Hyaluronic acid was obtained 
mainly in the 0.35 M LiCI fraction while dermatan-chondroitin sulfate 
and heparan sulfate were obtained in the 0.8 M LiCI fraction. 
Estimation of Gen.eral Protein. Synth esis 
Total protein synthesis was studied by incubating cultm ed fibro-
blas ts with ["H]-leucine after preincubation, wi th the different steroids. 
After 6 hr of ["H]-Ieucine incubation the cells were hru·vested as above. 
The celJs were suspended in 10% trichloroacetic acid (TCA). After 
sonication for 20 sec the samples were centrifuged at 8,000 X g for 5 
min. The pelJet was washed 3 times with 10% TCA and finally dissolved 
in 0.5 ml of 0.5 M sodium hych oxide. 
Analytical and Separatory M ethods 
Ion-exchange chromatography was canied out on columns (10 x 25 
mm) of DE-52 DEAE cellulose as desc ribed above. Before structural 
s tudies the sulfated glycosaminoglycans were further purified on col-
umns (10 X 25 mm) of DE-52 celJu lose ion-excha nge as described by 
Sjoberg et al [14]. Hepru·an sulfate and derma tan sulfate were obtained 
in the 3.0 M pyridine acetic acid fraction. 
Gel chromatography was cruTied out on columns (8 X 144 mm) of 
Sephadex G-50 eluted by 0.05 M NH .. H CO, in a rate of 10 ml/Iu·. 
Radioactivity was determ~ned in a Packard (2650) Tri-Cru·b liquid-
scint illation coun ter with automatic quench-correction. 
Protein was determined as described by Lowry et al [15] wi th bovine 
serum albumin as standard, and the DNA content by the method of 
Hill a nd Whatley (16]. 
Structural Studies 
One portion of the sulfated glycosaminoglycans was treated with 
nitrous acid which depolymerizes heparan sulfate but does not attack 
ga lactosaminoglycans [17]. Another port ion was digested with chon-
droitinase-ABC as described by Cru·lstedt et al [18]. The products of 
these degradations were subjected to gel chromatography on Sephadex 
G-50. In the fo rmer procedure derma tan sulfate is obtained in the void 
volume and heparan sulfate split products ru·e retru·ded. T he latter 
procedure yields intact hepru·an sul fate in the void volume whereas 
degraded derma tan sulfate was more retarded. Derma tan sulfate was 
also subjected to fur ther digestion with chondroitinase-AC [18]. This 
treatment was followed by gel chromatography on Sephadex G-50 in 
order to study the distr ibution of glucuronic ac id and iduronic acid 
containing saccharides. 
Statistical M ethod 
All values reported represent the mean ± the s tandard error of the 
mean (SEM) of at least 10 observat ions. S ignificrulces ru·e calculated 
according to two-sided paired t-tests. Diffe rences were considered sig-
nificant when p < 0.05. 
RESULTS 
E ffect of Glucocorticoids on the Accumulations of Labeled 
Glycosaminoglycans in the Cell Culture 
B udesonide, a synthetic pote n t glucocorticoid [9], induced a 
dose-response related decrease of t he accumulation of 3H_Ia_ 
beled glycosaminoglycan s in the m edium, in th e cell surface 
fraction (tl'ypsin digest of th e cell layer), a nd in the cells (cells 
obta ined after trypsin digestion) (Fig 1) . The decrease was most 
promine n t in th e m edium; a 10- r. M concentration of budesonide 
induced a 70% inhibition of both :IH -la beled h yaluronic acid 
and sulfated 'IH-Iabeled glycosaminoglycans. The dose-r elated 
decrease of :IH accumulation was similar for h yaluronic acid 
and sulfated 3H-labeled glycosaminoglycans. A dose-response 
r elated inhibit ion was a lso obtained with C5S]-suliate incorpo-
r a tion (Fig la) into the glycosaminoglycans of t h e m edium 
(Table I) , but t h e 35S-incorporation was less inhibited t h an t h e 
corresponding :JH-incorporation (Table I, Fig 1). T h e accumu-
lation of the cell surface-associated glycans was not inhibited to 
the same extent as th at of t h e glycan s of th e medium (Fig Ib) 
and 10- 5 M of budesonide cau sed only a 25- 60% decrease (Table 
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FIG 1. Effects of budesonide on glycosaminoglycan accumulation in 
the medium (a), the cell surface fraction (b), and the remaining cells 
( e). Glycosaminoglycan accumulation during a 48-hr pulse of 30 SO .. and 
["H]-glucosamine was m easured after 24 Iu· of budesonide preincuba-
tion. T he glycans were sepru·ated into nonsulfated and sulfated fractions 
as described in Materials and Methods. The values were obtained from 
one typical experiment and are given as percentage of control. 3H_ 
labeled hyaluronic acid, ; 3H-labeled sul fated glycosaminogly-
cans, - - -; and :loS-labeled glycosaminoglycans, . . . . . . 
TA BLE 1. Effect of glu.cocorticoid treatm.ent all. the am.ou.nt of 
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Fibroblasts in cultme were incubated with budesonide (10 5 M), 
3"80,,_ and "H-Iabeled glucosamine as described in Materials and Meth -
ods. Hyaluronic acid a nd sulfa ted glycosaminoglycans were isolat.ed by 
ion exchange chromatography. Mean ± S.E.M. from 6 experiments ru·e 
given in percent of un treated cultures. 
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intermediate extent, compared with the m edium and the cell 
surtace fractions (Fig I e). 
In order to investigate whether different glucocorticoids in-
fluence cultured fibroblasts differently, 3 steroids were tested 
with respect to the accumulation of glycosaminoglycans in the 
medium. As can be seen in Fig 2a, hydrocortisone affected only 
t he incorporation of [3H]-glucosamine into hyaluronic acid to a 
small extent at t he concentration 10- 0 M. Budesonide and 
fluocinolone acetonide, however, strongly decreased the glycos-
aminoglycan secretion, and at 10- 0 M they inhibited hyaluronic 
acid synthesis by at least 60%. At lower concentration smaller 
effects were noted especially for budesonide (Fig 2a). When the 
accumulation of 3H-Iabeled sulfated glycosaminoglycans was 
examined, very similar dose-response curves for the respective 
steroids to those of hyaluronic acid synthesis were obtained 
(Fig. 2b) . Again fluocinolone acetonide strongly inhibited secre-
tion of 3H-Iabeled glycosaminoglycans into the m edium; thus, 
no change of the relative amounts of hyaluronic acid and 
sulfated giycans could be observed in the medium with respect 
to the glycans. The incorporation of 358 0" into excreted glycos-
aminoglycans showed a similar inhibition, although to a smaller 
extent, than the CH]-glucosamine incorporation. Hydrocorti-
sone was nearly ineffective at all concentrations, while fluoci-
nolone acetonide and budesonide inhibited the synthesis 40-
50% at 10- 0 M (Fig 2e). 
Both protein- and DNA-content of treated and control cul-
tures were measured . No change in total amount of either 
protein or DNA between control and budesonide-treated cul-
t ures was noted (Table II). Furthermore, no effect caused by 
budesonide on the general protein synthesis, measw·ed by 
CH]-leucine incorporation into TeA-precipitable protein, was 
observed (Table II) . 
Effect of Glucocorticoid Treatment on the Distribution of 
Various Glycosaminoglycans in the Cell Culture 
After 48 hr of incorporation of radioactive precursor the main 
part of the synthesized hyaluronic acid and sulfated glycosami-
TABLE Il. Effect of g lucocorticoid treatment on DNA and protein 
content in cells 
Budesonide concentration 
to- II M to- " M 10- ' M 10- " M 
DNA 93 ± 7 98 ± 3 94 ± 6 94 ± 6 
n =6 
Protein 110 ± 19 95 ± 10 107 ± 15 96 ± 12 
Folin value 
n =4 / -




Cultul"es were preincubated with budesonide for 24 111". DNA and 
protei n were determined after additional 48 hl· incubation. ["H]-leucine 
incorporation in to cellulru· proteins was measured after preincubation 
with a 6-hr pulse. S imilar effects on ["H]-Ieucine incorporation were 
found in the medium and cell sUl"face fraction. The results are given in 
mean ± S.E.M. as percent of untreated cultures. N.D. = not done. 
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noglycans was found in the medium (Ta ble III). Budesonide 
treatment (10- " M) changed the distribution of glycans between 
the various compartments to some extent. After treatment a 
relative decrease of the glycans of the medium and a corre-
sponding increase of those of the cell surface fi·action were 
noted (Table III) . The proportion of glycosaminoglycans intra-
cellularly was not changed to any large extent (Table III). Both 
hyaluronic acid and sulfated glycosaminoglycans of the medium 
were decreased to the same degree by the treatment. In the cell 
surface fraction, however, hyaluronic acid was nearly doubled 
(Table III). In absolute amounts only a 30-40% decrease of 
hyaluronic acid in the cell swface fraction was noted, while it 
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FIG 2. Screening of glucocorticoids effect on hyaluronic acid ( a.), 
"H-labeled sulfated glycosaminoglycans (b) , and a"S04-labeled sulfated 
glycosaminoglycans (c) in the medium. Fibroblasts in culture were 
preincubated with steroids. After 24 hr ""S04- and aH-labeled glucosa-
mine were added, and after an additional 48 hr sulfated glycosamino-
glycans and hyalul"Onic acid were isolated as described in MateJ·ia ls a nd 
Methods. Effect of hydl"Ocortisone, .. .. .. ; effect of budesonide, 
---; effect of fluocinolone acetonide - - -. 
TABLE III. Distribution of [JH} ·glycosaminoglycans in un.treated and g lucocorticoid· treated cultures 
Total ["H).glycosaminoglycans ["H]-hyaluronic acid ["H)·sultilted glycosaminoglycnll 
Fraction Untreated Treated Untreated Treated Untreated Treated 
(%) (%) (%) (%) (%) (%) 
Medium 72 ± 1 67 ± 2 80 ± 2 74 ± 3 55 ± 3 50 ± 3 
Cell surface pool 15 ± 2 20 ± 3 9±1 15 ± 3" 27 ± 4 31 ± 4' 
Cells 13 ± 2 13 ± 2 12 ± 2 11 ± 1 18 ± 3 20 ± 4 
Cul tures were treated with budesonide 10- 0 M and after 24 hr [aH]-glucosamine was added. After 48 111" hyaluronic acid and sulfated 
glycosaminoglycans were isolated as described in Materia ls a nd Methods. The data are compiled from 10 different observations and given as 
percentage of the total a moun t of glycosaminoglycan, hyaluronic acid, a nd sulfated glycosaminoglycan, respectively. 
' p < 0.05. 
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Glucocorticoid-Induced Changes of the R elative Proportion 
and Distribution of Den natan Sulfate and Heparan Sulfate 
The effect of budesonide treatment (10- 5 M) on the compo-
s it ion of the sulfated glycosaminoglycans was assessed by spe-
c ific degradations. The relative amounts of heparan sulfate and 
derma tan sulfate were determined either by nitrous acid deg-
radation or by ch ondl'Oitinase-ABC digestion followed by duo-
matography on Sephadex G-50, which separates degraded from ' 
nondegraded material. B udesonide treatment affected the 2 
TABLE IV. Effect of glucocorticoids on the relative am.ounts of 
hepara.n sulfate in the various compartments 
Fraction Untreated Treated (%) (%) 
Medium 18 12 
Cell surface pool 42 62 
CeUs 17 32 
Fibroblasts in cultUl'e were treated with budesonide (10-" M) and 
["H]-glucosamine as described in Materials and Methods. Su lfated 
glycosaminoglycans were isolated [TOm the 3 compartments as de-
scribed. The proportion of heparan su lfate of the sulfated glycosami-
noglycans was determined by either nitrous acid degradation 01' chon-
droitinase-ABC digestion foUowed by chromatography on Sephadex G-
50. The two methods gave identical resul ts. Data from one typical 
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polysaccharides differently (Table IV). A relative decrease of 
heparan sulfate compared to derma tan sulfate in the medium 
was noted, while the proportion of heparan sulfate in the cell 
surface fraction increased from 42% to 62%. The most marked 
change in the proportion of heparan sulfate was noted intracel-
lulal'ly where a 2-fold relative increase was recorded. 
In total amou nts, th e accumulation of derma tan sulfate de-
creased to the same extent, 60- 70% compared to control cuI-
tlU'es in all fractio ns, while the accumulation of heparan sulfate 
decreased 70- 80% in the medium, 30-40% in the cell slU'face-
derived fraction, and only 20-30% intracellularly. 
E ffect of Glucocorticoid T reatment on the Copolymeric 
Structure of Dermatan Sulfate 
Dermatan sulfate obtained after nitrous acid degradation was 
subjected to digestion by ch ondroitinase-AC. This enzyme 
cleaves glycosidic linkages between N -acetyl-galactosamine and 
glucuronosyl residues while th ose to iduronosylresidues are left 
intact. Thus, after digestion and separation on a column of 
Seph adex G-50, sacch arides clU'omatographing in the total vol-
ume arise from glucuronosyl-con taining sequences, while those 
in the void volume are composed mainly of L-idlU'onosyl resi-
dues. In nonsteroid- treated cultlU'es the glycans of the cells 
contained mainly idlU'onic acid residues (Fig 3c), while glycans 
of th e medium contained a somewhat higher proportion of D-
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FIG 3. Gel chromatograms of chondl'Oitinase-AC digests of dermatan sulfate obtained [Tom the med ium (a and d), t he cell surface pool (b and 
e) , and ceUs (c and f) of control and glucocorticoid (budesonide 10-" M)-treated fibroblast cultures, respectively. Dermatan sulfate was isolated 
from various compartments of treated (d-f) and non treated (a-c) fibroblast cultures. The copolymeric structUl'e was elucidated by chondroitinase-
AC digestion fo llowed by chromatography on a column (0.8 x 140 cm) of Sephadex G-GO. The flow was 10 ml per hI', and fractions of 2.6 ml (a, 
d) , 3.4 011 (b. e), and 2.4 011 (c-f) were collected. The material obtained in the void volume of the colu mn is regru'ded as iduronic acid-containing 
components, while the included material is regarded as glucuronic acid-containing. This approximation introduces a small errol' as the void 
volume can contain maximally 12% of glucuronic acid. The included material is more than 90% disacchru'ides which originate from glucuronic acid 
residues. The longer oligosaccharides (less than 10%) contain small amounts of iduronic acid residues [18]. Radioactivity of [3H]-glucosamine, 
----; radioactivity of e "S]-sulfate, - - - - -. 
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TABLE V. Effect of g lucocorticoid trea.tment on the copolymeric 
structure of derm.a.tan sulfate 
Fraction 








Medium 45 33 
Cell surface pool 108 48 
~~ ~ ~ 
Fibroblasts in culture were treated with budesonide (10- " M), ""SO,\ 
and ["H]-glucosamine, and sulfated glycosaminoglycans were isolated. 
Heparan sulfate was removed after nitrous acid treatment by chroma-
tography on a column of Sephadex G-50. The copolymeric structure of 
dermatan sulfate was investigated after chondroitinase-AC digestion 
fol.lowed by gel chromatography (Fig 3). The material in the Vo-volume 
is regarded as idW'onic acid components, while those chromatographing 
as retarded are calculated as glucuronic ac id-containing material. The 
data from one typical experiment are given as percentage of the 
material obtained in the Vo and retarded, respectively, of untreated 
cul tw·es. 
cans were rich in D-glucuronosyl residues with a large propor-
tion of the radioactivity cllJ'omatog:raphing as disaccha:rides 
after chondroitinase-AC digestion (Fig 3b). 
Budesonide treatment (10- 5 M) changed the copolymeric 
structure of dermata n sulfate in the direction of a decreased 
proportion of D -glucuronosyl residues (Fig 3d-f, Table V). 
Thus, the amount of D-glucuronic acid-containing disaccha-
rides of glycans in the medium decreased more (down to 33% of 
the control) than did the iduronic acid (down to 45% of the 
control) . Such a change was evident also for glycans of the cells. 
The dermatan sulfate of the cell surface is the fraction that 
normally contains most glucul'onic acid residues (Fig 3b). In 
this fraction budesonide induced the largest change in relative 
composition (Fig 3e, Table V). Compared to control cultures, 
no decrease of the iduronosyl mate rial was observed, while a 
48% decrease of the glucuronosyl-containing components was 
recorded. Thus, the glucocorticoid treatment resulted not only 
in an abso lute decrease but also in a change of the copolymeric 
structure . of derma tan sulfate, especially in the cell sUl'face 
fraction. 
DISCUSSION 
Fibrous connective tissue is difficult to study metabolically 
in vivo and therefore many workers have turned theil' attention 
to cultured fibroblasts [6] for investigating the effects of gluco-
corticoids. Depending on the actual glucocorticoid, its concen-
tration, a nd preincubation time, varying effects on the glycos-
aminoglycan synthesis have been reported, from slightly stim-
ulatory to highly inhibitory [19]. In the present study a clear 
inhibition of the glycosaminoglycan-synthesis and -excretion 
into the medium was demonstrated at concentrations::::: lO- r, 
M for hydl'ocor tisone, ::::: 1O- u_1O-7 M for budesonide, and even 
down to 10- 11 M for fluocinolon e acetonide. There was a deviat-
ing slope of the dose-response relationship for budesonide com-
pared with those of the other 2 glucocorticoids. This deviation 
seems not to depend on varying biotransformation of the glu-
cocorticoids dW'ing the incubation period, as neither hydrocor-
tisone nor budesonide [20] (Sarns trand, unpublished) nor fluo-
cinolone acetonide [21] are biotransformed to any greater extent 
by fibroblasts. 
It should be noted that the effect of the 2 potent glucocorti-
coids on glycosaminoglycan synthesis and sec retion was ob-
tained at concentrations where no effect of general protein 
synthesis could be recorded. Furthermore, no decrease of either 
DNA nor of protein content was detected. This is in accordance 
with other investigations [4). The inhibition of glycosaminogly-
can synthesis therefore seems to be a result of an effect on some 
specific step in the synthesis or on the formation' of precursors. 
In the present study the fibroblasts were preincubated for 24 
hl' with glucocorticoids to ensure a sufficient lag time for the 
glucocorticoid action before the radioactive precursors were 
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added. The results demonstra te that the incorporation of ["H]-
glucosamine into hyaluronic acid and sulfated glycosaminogly-
cans of the medium was inhibi ted to the same extent. This 
suggests that a common and early step in thei.r synthesis was 
affected. However, the '15S0. and eH]-glucosamine incorpora-
tion into the sulfated glucosaminoglycans differed . This can be 
explained either by an oversulfation or by a change in the 
specific ac tivity of the nucleotide precu.rsors. Preliminary data 
indicated that the specific activity ofUDP-N-acetylhexosamine 
pool was diminished by steroid treatment (Sarnstrand, unpub-
lished). Although there was a difference in the decrease of :IH 
and :J5SO'1 incorporation, the relative composition and distribu-
tion of a" SO.-labeled glycans were similar to those of aH-labeled 
glycans. As a majority (65-80%) of the glycans are secreted to 
the medium, it was considered most relevant to use a screening 
method to determine the effect of various substances on gly-
cosaminoglycan metabolism. The adopted method, involving 
preincubation with the test substance, precursor incorporation, 
and isolation of labeled glycosaminoglycans, offers the possibil-
ity to screen effects on cells fTom difi'erent tissues and animals. 
The method might be of special interest for the development of 
glucocorticoid derivatives with relatively less efi'ect on connec-
tive tissue. 
The effects of one of the glucocorticoids (budesonide) were 
studied in more detail. It became evident that the various 
polysaccha:rides on the cell surface and in the cell fraction were 
influenced di.fferently compared with those of the medium 
fraction. Especially noticeable was the smaller extent of inhi-
bition of glycosaminoglycans in the cell surface fraction, which 
was due to smaller effect on hyaluronic acid and heparan sulfate 
than on dermatan sulfate. Heparan sulfate is most likely a n 
integral macromolecule of the cell membrane [22] and it has 
been ascribed hypothetical functions in cell-to-cell interaction 
and shielding of the cell surface. Hypothetical receptors at the 
cell surface have also been described for hyalul'Onk acid [23]. 
In any event, these glycans might have important functions at 
the cell surface and are therefore selectively retained during 
glucocortocoid treatment. D ermatan sulfate, which probably 
has its main function in the matrix, in vivo might not bp. as 
important for the immediate sw'vival of the cell. 
The function of dermatan sulfate proteoglycans in fibrous 
connective tissue is obscure. They have been ascribed functions 
in waterbinding, self-self interaction to form gels, and, probably 
most important, an effect on collagen fibril formation [24-26]. 
In some of these functions the copolymeric structure of the side 
chains and mixture of different proteoglycans is of importance. 
A changed structure might then impair or change the functions 
of the whole tissue. The effect of glucocorticoid treatment on 
the copolymeric structlll'e of derma tan sulfate was therefore 
investigated. A decrease of glucuronic acid-containing disaccha-
rides compared to iduronic acid-containing ones was then de-
tected. This effect was especially conspicuous in the glycans of 
the cell surface. At the present stage it is difficult to judge 
whether the change affects aU dermatan sulfates or only a 
fraction of them and what effect this change has on cell function. 
Recently, it has been shown that skin fibroblasts in cultW'e 
synthesize 2 types of proteoglycans, one containing side chains 
rich in glucuronic acid and one that is rich in iduronic acid 
(18). Preliminary data indicate that the former is more inhibited 
by budesonide than the latter (Sarnstrand, unpublished) . 
In conclusion, glucocorticoid treatment not only changes the 
amount of proteoglycans in and around the treated cells but 
can also induce a change in distribution between matrix and 
cell-pericellulru' domain and a change of the derma tan sulfate 
structure. The decreased content of proteoglycans combined 
with a changed proportion and change of structure of various 
species aj'e most likely important factors for the development 
of skin atrophy. 
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Identification, Characterization, and Partial Purification of Mammalian 
Skin Wound Hyaluronidase 
CHARLES N. BERTOLAMI, D.D.S., D .MED.8C. AND R. BRUCE DONOFF, D.M.D., M.D. 
Depa.rtm.ent of Oml Surge/y, School of Denta.l Medidn e, Universl:ty of Connecticut, Farmington, Connecticut, and Massachusetts Geneml 
Hospital, Boston, Ma.ssaclwsetts, U.S.A. 
A recently described mammalian wound hyaluroni-
dase is successfully characterized and partially purified 
in the current study. Peak enzyme activity occurred on 
postwound day 7, pH optimum 4.5. Both crude and pu-
r ified wound enzyme exhibited endoglycosidic activity 
against hyaluronate and chondroitin-4-sulfate but not 
against chondroitin-6-sulfate or derma tan sulfate. A 5.3-
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Abbreviations: 
GAG : giycosaminogiycan 
PAGE: polyacrylamide gel electrophoresis 
fold increase in activity was obtained by the DEAE-
Sephadex purification technique described. Polyacryl-
amide gel electrophoresis yielded a single major band 
near the gel's midrange and one minor band of lesser 
electrophoretic mobility. These enzyme characteristics 
support a- biochemical analogy, b etween .tissue repair in 
skin and numerous developmental systems and may also 
provide a simple means for enzymatic differentiation 
among chondroitin sulfate isomers. 
In mammalian wound repair, early cellular proliferation and 
ground substance synthesis are followed by the resorptive and 
remodelling processes which collectively constitute wound 
"maturation." Mechanisms which control the collagenous, cel-
lular, and glycosaminoglycan (GAG) composition of wound 
granulation t issue remain unknown. 
Balazs and Holmgren [1] suggested t hat wound granulation 
t issue contained predominantly nonsulfated GAG during the 
